4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-19-032141
Options or other derivatives
- CEO, President and Secretary acquired 187,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mehta Vimal CEO, President and Secretary | 2019-05-23 | Grant or award · Stock Option (Right to Buy) | +187,700 | 187,700 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…